Volume 7, Number 2—April 2001
THEME ISSUE
4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections
State of the Art
Engineering out the Risk of Infection with Urinary Catheters
Table 4
Studies of novel technologies for preventing catheter-associated urinary tract infection
| Technologic innovation (refs) | Risk reduction in randomized trials |
|---|---|
| Antiinfective lubricant (2) | Unproven |
| Sealed catheter-collection tubing junctions (38–40) | Unproven |
| Antireflux valves (2) | Unproven |
| Continuous irrigation of bladder with antiinfective solution (2,37) | Unproven |
| Instillation of antiinfective into collection bag (2) | Unproven |
| Antiinfective catheter material | |
| Antimicrobial drug-impregnated | |
| Nitrofurazone (20) Minocycline-rifampin (21) Silver oxide (29,30,42) Silver-hydrogel (22–25,27,42) | 0.7 (0.3a) 0.4 Unproven 0.2-0.7 |
CAUTI = catheter-associated urinary tract infection
aFor bacterial CAUTI.


